Eurolyser Diagnostics - Premium Laboratory Equipment

NEW: Immunologic FOB test kit for colorectal cancer screening for smart point of care platform

Wednesday, 10. November 2010

Due to its easy handling and the fact of lowering the mortality quote fhe fecal occult blood (FOB) test is the most common screening test for the colorectal carcinoma at the present. Disadvantages of existing tests are insufficient sensitivity – especially when indicating early stages of the carcinoma – and a low public acceptance.

The new smart point of care immunologic FOB is more specific and more sensitive.

It is based on the detection of human haemoglobin by using specific antiobodies and is therefore indipendent of dietary or medicinal factors resulting in a higher public acceptance. The detection of tumour-DNA in stool by use of the smart FOB test dawns a new area of detecting colorectal carcinoma at an early stage. The full quantitative test enables to detect and display precise concentrations.

Smart FOB test advantages at a glance:

  • immunologic test
  • independent of dietary or medicinal factors
  • full quantitative results
  • early detection of colorectal carcinomas

Eurolyser News

28. November 2013

Cystatin C: new Point-of-Care assay for renal diagnostics and diabetes monitoring...
» Read more...

14. October 2013

Visit us! Eurolyser at the Medica 2013 in Dusseldorf & Arab Health 2014 in Dubai...
» Read more...

22. May 2013

FOB-Quick Test: Eurolyser and Sentinel Diagnostics from Milano, Italy start cooperation...
» Read more...

2. April 2013

New test for POC instruments: Troponin I...
» Read more...